Special Issue on The Relation Between Age Related Macular Degeneration and Thyroid Disorders

Submission Deadline: May 20, 2020

Please click the link to know more about Manuscript Preparation: http://www.ijovs.org/submission

Please download to know all details of the Special Issue

Special Issue Flyer (PDF)
  • Lead Guest Editor
    • Mona Abdelkader
      Assistant Professor in Ophthalmic Center, Mansoura University, Mansoura, Egypt
  • Guest Editor
    Guest Editors play a significant role in a special issue. They maintain the quality of published research and enhance the special issue’s impact. If you would like to be a Guest Editor or recommend a colleague as a Guest Editor of this special issue, please Click here to complete the Guest Editor application.
    • Naglaa Abass
      Mansoura Medicine Hospital, Mansoura, Egypt
  • Introduction

    Age related macular degeneration (ARMD) is one of the causes of visual loss worldwide and increasing in prevalence. The pathophysiology of ARMD is complex. Drusen is initiated by inflammatory cells and activated by complement formation while the cause of pigment alteration is still unclear. Thyroid hormones regulate different visual functions. Human retinal pigment epithelial (RPE) cells express thyroid hormone receptors that are target for thyroid hormone. Suppression of thyroid hormone preserves cone photoreceptors in mouse with retinal degeneration. While, administration of active thyroid hormone deteriorates cones.
    Thyroid dysfunctions are common, with prevalence up to 10%. Thyroid disorders are associated with alterations in lipid levels, atherosclerosis, and hypertension which are predisposing factors for ARMD development. Some studies have shown that the use of thyroid hormones is associated with AMD while another study did not establish such relationship.
    The purpose of the special issue is to determine the relation between thyroid disorders and thyroid hormones and ARMD.

    Aims and Scope:

    1. T3
    2. T4
    3. Tsh
    4. Armd (Age Related Macular Degeneration)
    5. Hyperthyroidism
    6. Hypothyroidism

  • Guidelines for Submission

    Manuscripts can be submitted until the expiry of the deadline. Submissions must be previously unpublished and may not be under consideration elsewhere.

    Papers should be formatted according to the guidelines for authors (see: http://www.ijovs.org/submission). By submitting your manuscripts to the special issue, you are acknowledging that you accept the rules established for publication of manuscripts, including agreement to pay the Article Processing Charges for the manuscripts. Manuscripts should be submitted electronically through the online manuscript submission system at http://www.sciencepublishinggroup.com/login. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal and will be listed together on the special issue website.

  • Published Papers

    The special issue currently is open for paper submission. Potential authors are humbly requested to submit an electronic copy of their complete manuscript by clicking here.